Hong Kong stock market surged | Miwei Biotechnology-B (02493.HK) rose by over 23%, with results of 9MW2821 for cervical cancer clinical research set to be announced at the 2026 ESMO GC.

According to the Securities Times app, Maiwei Biotechnology-B (02493.HK) surged more than 23%, reaching a record high of 31.46 Hong Kong dollars. As of press time, it has risen by 14.36%, closing at 29.14 Hong Kong dollars, with a turnover of 1.4 billion Hong Kong dollars.